Department of Physiology and Dental Research Institute, Seoul National University School of Dentistry, Seoul 03080, Republic of Korea.
Department of Neural Development and Disease, Korea Brain Research Institute, Daegu 41068, Republic of Korea.
J Neurosci. 2018 Apr 4;38(14):3571-3583. doi: 10.1523/JNEUROSCI.2081-17.2018. Epub 2018 Mar 12.
Mutations in the () gene cause human intellectual disability, one of the most common cognitive disorders. However, the molecular mechanisms of -related intellectual disability remain poorly understood. We investigated the role of in synaptic function and animal behavior using male mouse and models. knock-out (KO) mice showed normal brain and spine morphology as well as intact synaptic plasticity; however, they also exhibited decreases in synaptic transmission and presynaptic release probability exclusively in excitatory synapses. Presynaptic function was impaired not only by loss of CRBN expression, but also by expression of pathogenic CRBN mutants (human R419X mutant and G552X mutant). We found that the BK channel blockers paxilline and iberiotoxin reversed this decrease in presynaptic release probability in KO mice. In addition, paxilline treatment also restored normal cognitive behavior in KO mice. These results strongly suggest that increased BK channel activity is the pathological mechanism of intellectual disability in mutations. (), a well known target of the immunomodulatory drug thalidomide, was originally identified as a gene that causes human intellectual disability when mutated. However, the molecular mechanisms of CRBN-related intellectual disability remain poorly understood. Based on the idea that synaptic abnormalities are the most common factor in cognitive dysfunction, we monitored the synaptic structure and function of knock-out (KO) animals to identify the molecular mechanisms of intellectual disability. Here, we found that KO animals showed cognitive deficits caused by enhanced BK channel activity and reduced presynaptic glutamate release. Our findings suggest a physiological pathomechanism of the intellectual disability-related gene and will contribute to the development of therapeutic strategies for -related intellectual disability.
()基因突变导致人类智力障碍,是最常见的认知障碍之一。然而,CRBN 相关智力障碍的分子机制仍知之甚少。我们使用雄性小鼠和 模型研究了 在突触功能和动物行为中的作用。 敲除(KO)小鼠表现出正常的大脑和脊柱形态以及完整的突触可塑性;然而,它们还表现出兴奋性突触中突触传递和突触前释放概率的减少。突触前功能不仅受到 CRBN 表达缺失的影响,还受到致病性 CRBN 突变体(人 R419X 突变体和 G552X 突变体)的表达的影响。我们发现 BK 通道阻滞剂 paxilline 和 iberiotoxin 逆转了 KO 小鼠中突触前释放概率的这种降低。此外,paxilline 处理还恢复了 KO 小鼠的正常认知行为。这些结果强烈表明,BK 通道活性的增加是 突变导致智力障碍的病理机制。(),一种免疫调节药物沙利度胺的已知靶点,最初被确定为突变时导致人类智力障碍的基因。然而,CRBN 相关智力障碍的分子机制仍知之甚少。基于突触异常是认知功能障碍最常见因素的想法,我们监测了 KO 动物的突触结构和功能,以确定智力障碍的分子机制。在这里,我们发现 KO 动物表现出认知缺陷,这是由增强的 BK 通道活性和减少的突触前谷氨酸释放引起的。我们的研究结果表明,与智力障碍相关的基因 存在生理病理机制,并将有助于开发与 CRBN 相关智力障碍相关的治疗策略。